Latest Articles

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

APSC Consensus Recommendations on Dyslipidemia

VTE incidence after cesarean delivery

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

What do us physicians and patients think about LLTs and goals of treatment?

Physician and patient perceptions of benefits, risks, and treatment goals of lipid-lowering therapy: Results from GOULD registry.

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Hypercholesterolemia Treatment Patterns and Lipid Target in ACS Patients: HYDRA-ACS Registry

EAS guidance regarding combining Lipid-modifying therapy